See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
NFL
Soccer
Cricket
Social Media
Natural Disasters
Donald Trump
Catholic Church
Premier League
Rugby
Baseball
Artificial Intelligence
Published • loading... • Updated

CRISPR's CEO got a big payday

Summary by STAT
Today's biotech news features Bristol’s schizophrenia drug disappointment, AstraZeneca joining PhRMA as tariffs loom, and more.

1 Articles

All
Left
Center
1
Right
STATSTAT
Center

CRISPR's CEO got a big payday

Today's biotech news features Bristol’s schizophrenia drug disappointment, AstraZeneca joining PhRMA as tariffs loom, and more.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Wednesday, April 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tariffs

Tariffs

CRISPR

CRISPR

Boston, Massachusetts

Boston, Massachusetts

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal